Anthropic details early drug-development work using Claude

Anthropic said it has partnered with six drug developers and advanced internal programs, with early preclinical results across oncology, allergies and muscular dystrophy. (Read More)

BeCrypto News shows a short excerpt and links to the publisher. The full report belongs to Blockchain.News.